The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Immunotherapy of Cytotoxic T Cell–resistant Tumors by T Helper 2 Cells
Open accessAbstract
Currently most attempts at cancer immunotherapy involve the generation of CD8+ cytotoxic T lymphocytes (CTLs) against tumor-associated antigens. Many tumors, however, have been immunoselected to evade recognition by CTLs and thus alternative approaches to cancer immunotherapy are urgently needed. Here we demonstrate that CD4+ T cells that recognize a secreted tumor-specific antigen and exhibit a cytokine secretion profile characteristic of Th2 cells, are capable of clearing established lung and visceral metastases of a CTL-resistant melanoma. Clearance of lung metastases by the Th2 cells was found to be totally dependent on the eosinophil chemokine, eotaxin, and partially dependent on the transcription activator signal transducer and activator of transcription 6 (STAT6), with degranulating eosinophils within the tumors inducing tumor regression. In contrast, tumor-specific CD4+ Th1 cells, that recruited macrophages into the tumors, had no effect on tumor growth. This work provides the basis for a new approach to adoptive T cell immunotherapy of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,633
Essential role of Stat6 in IL-4 signalling
Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S.-I., Nakanishi, K., Yoshida, N., Kishimoto, T., & Akira, S. (1996) · Nature · doi:10.1038/380627a0 · Cited by 1,557 · cited 1×
“Furthermore, the reduced capacity of Th2 cells to eliminate tumors in STAT6-deficient mice is consistent with eotaxin playing an essential role in tumor clearance as eotaxin production by lung epithelial cells is largely dependent on signaling by the IL-4R–STAT6 pathway (21, 22).”
BackgroundThe IL-4 receptor: signaling mechanisms and biologic functions
Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.701 · Cited by 1,545
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
Shimoda, K., van Deursent, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A. A., et al. (1996) · Nature · doi:10.1038/380630a0 · Cited by 1,278 · cited 1×
“Furthermore, the reduced capacity of Th2 cells to eliminate tumors in STAT6-deficient mice is consistent with eotaxin playing an essential role in tumor clearance as eotaxin production by lung epithelial cells is largely dependent on signaling by the IL-4R–STAT6 pathway (21, 22).”
BackgroundAssociation of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
Introduction of soluble protein into the class I pathway of antigen processing and presentation
Moore, M. W., Carbone, F. R., & Bevan, M. J. (1988) · Cell · doi:10.1016/s0092-8674(88)91043-4 · Cited by 1,092
Rothenberg, M. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805283382206 · Cited by 834
Self-citationMurine interleukin-4 displays potent anti-tumor activity in vivo
Tepper, R. I., Pattengale, P. K., & Leder, P. (1989) · Cell · doi:10.1016/0092-8674(89)90925-2 · Cited by 778
Ossendorp, F., Mengedé, E., Camps, M., Filius, R., & Melief, C. J. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.693 · Cited by 610
An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4
Tepper, R. I., Coffman, R. L., & Leder, P. (1992) · Science · doi:10.1126/science.1636093 · Cited by 541
Fluorescent dyes for lymphocyte migration and proliferation studies
Parish, C. R. (1999) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.1999.00877.x · Cited by 473
Self-citationDistinct Role of Antigen-Specific T Helper Type 1 (Th1) and Th2 Cells in Tumor Eradication in Vivo
Nishimura, T., Iwakabe, K., Sekimoto, M., Ohmi, Y., Yahata, T., Nakui, M., Sato, T., Habu, S., Tashiro, H., Sato, M., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.617 · Cited by 468
Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors
Crowther, M., Brown, N. J., Bishop, E. T., & Lewis, C. E. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.4.478 · Cited by 415
CD4+T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ
Mumberg, D., Monach, P. A., Wanderling, S., Philip, M., Toledano, A. Y., Schreiber, R. D., & Schreiber, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8633 · Cited by 384
A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation
Hogan, S. P., Mishra, A., Brandt, E. B., Royalty, M. P., Pope, S. M., Zimmermann, N., Foster, P. S., & Rothenberg, M. E. (2001) · Nature Immunology · doi:10.1038/86365 · Cited by 303
Self-citationTominaga, A., Takaki, S., Koyama, N., Katoh, S., Matsumoto, R., Migita, M., Hitoshi, Y., Hosoya, Y., Yamauchi, S., & Kanai, Y. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.2.429 · Cited by 298
Mochizuki, M., Bartels, J., Mallet, A. I., Christophers, E., & Schröder, J.-M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.60 · Cited by 291
Inhibition of Angiogenesis by Interleukin 4
Volpert, O. V., Fong, T., Koch, A. E., Peterson, J. D., Waltenbaugh, C., Tepper, R. I., & Bouck, N. P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1039 · Cited by 255
Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells.
Matsukura, S., Stellato, C., Plitt, J. R., Bickel, C., Miura, K., Georas, S. N., Casolaro, V., & Schleimer, R. P. (1999) · PubMed · Cited by 236
Activation of Eotaxin Gene Transcription by NF-κB and STAT6 in Human Airway Epithelial Cells
Matsukura, S., Stellato, C., Plitt, J. R., Bickel, C., Miura, K., Georas, S. N., Casolaro, V., & Schleimer, R. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6876 · Cited by 195
Eotaxin: An Essential Mediator of Eosinophil Trafficking into Mucosal Tissues
Rothenberg, M. E. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.21.3.f160 · Cited by 170
Self-citationStrategies for immunotherapy of cancer
Melief, C. J. M., Toes, R. M., Medema, J. P., Van Der Burg, S. H., Ossendorp, F., & Offringa, R. (2000) · Advances in Immunology · doi:10.1016/s0065-2776(00)75006-1 · Cited by 165
Biological implications of macrophage infiltration in human tumor angiogenesis
Ono, M., Torisu, H., Fukushi, J.-I., Nishie, A., & Kuwano, M. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051101 · Cited by 157
IL-13 Induces Airways Hyperreactivity Independently of the IL-4Rα Chain in the Allergic Lung
Mattes, J., Yang, M., de Siqueira, A. L. P., Clark, K., MacKenzie, J. R., McKenzie, A. N. J., Webb, D. C., Matthaei, K. I., & Foster, P. S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1683 · Cited by 142
Self-citationKern, D. E., Klarnet, J. P., Jensen, M. C., & Greenberg, P. D. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.11.4303 · Cited by 96
Point Mutation in Essential Genes with Loss or Mutation of the Second Allele
Beck‐Engeser, G., Monach, P. A., Mumberg, D., Yang, F. E., Wanderling, S. S., Schreiber, K., Espinosa, R., Beau, M. M. L., Meredith, S. C., & Schreiber, H. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.3.285 · Cited by 46
Cited by
Smyth, M. J., Dunn, G. P., & Schreiber, R. D. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90001-7 · Cited by 870
Tumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 845
CD4 and CD8 T lymphocyte interplay in controlling tumor growth
Ostroumov, D., Fekete-Drimusz, N., Saborowski, M., Kühnel, F., & Woller, N. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2686-7 · Cited by 549
Carretero, R., Sektioglu, I. M., Garbi, N., Salgado, O. C., Beckhove, P., & Hämmerling, G. J. (2015) · Nature Immunology · doi:10.1038/ni.3159 · Cited by 501
Robust tumor immunity to melanoma mediated by interleukin-9–producing T cells
Purwar, R., Schlapbach, C., Xiao, S., Kang, H. S., Elyaman, W., Jiang, X., Jetten, A. M., Khoury, S. J., Fuhlbrigge, R. C., Kuchroo, V. K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2856 · Cited by 442
Metadata
- Authors
- Mattes, J., Hulett, M., Xie, W., Hogan, S., Rothenberg, M. E., Foster, P., & Parish, C.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-01-27
- Volume
- 197
- Issue
- 3
- Pages
- 387-393
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1964612175
- Cited by
- 256
- References
- 28
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.